Arvate, H. R. “Major Clinical Outcomes of the Action of the Co-Agonist Tirzepatide to Liraglutide and Semaglutide in the Treatment of Obesity and Type 2 Diabetes Mellitus: A Systematic Review”. International Journal of Nutrology, vol. 18, no. 1, Jan. 2025, doi:10.54448/ijn25102.